Role of dietary phosphorus and degree of uremia in the development of renal bone disease in rats

Renal Failure

Volumn 29, Issue 1, 2007, Pages 1-12

  Oste, Line ^a   Behets, Geert J ^a   Dams, Geert ^a   Bervoets, An R ^a   Marynissen, Rita L ^a   Geryl, Hilde ^a   Van Hoof, Viviane O ^b   De Broe, Marc E ^a   D'Haese, Patrick C ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Bone histomorphometry; Bone remodeling; Dietary phosphorus; Rat; Remnant kidney; Secondary hyperparathyroidism

Indexed keywords

ACID PHOSPHATASE; CALCIUM; DEOXYPYRIDINOLINE; MINERAL; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS; PYRIDINOLINE; TARTARIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BLOOD SAMPLING; BONE DISEASE; BONE TISSUE; CALCIUM BLOOD LEVEL; CHEMICAL ANALYSIS; CREATININE BLOOD LEVEL; DIETARY INTAKE; DISEASE SEVERITY; HISTOLOGY; KIDNEY DISEASE; MALE; NEPHRECTOMY; NONHUMAN; OSSIFICATION; OSTEOBLAST; PHOSPHATE BLOOD LEVEL; PHOSPHATE URINE LEVEL; PRIORITY JOURNAL; RAT; SECONDARY HYPERPARATHYROIDISM; UREMIA; URINALYSIS; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; BONE AND BONES; EATING; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; PHOSPHORUS, DIETARY; RATS; RATS, WISTAR; RENAL OSTEODYSTROPHY; UREMIA; URINE;

EID: 33846984634     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220601038637     Document Type: Article

References (43)

1. Hruska KA, Teitelbaum SL. Renal osteodystrophy. N Engl J Med. 1995;333:166-174.
2. Dabbagh S. Renal osteodystrophy. Curr Opin Pediatr. 1998;10:190-196.
3. Hamdy NA. The spectrum of renal bone disease. Nephrol Dial Transplant. 1995;10 Suppl. 4:14-18.
4. Hruska K. New concepts in renal osteodystrophy. Nephrol Dial Transplant. 1998;13:2755-2760.
5. Strauch M, Gretz N. Animal models to induce renal failure: a historical survey. Contrib Nephrol. 1988;60:1-8.
6. Chanutin A, Ferris EB. Experimental renal insufficiency produced by partial nephrectomy. Arch Int Med. 1932;49:767-787.
7. Faraj AH, Morley AR. Remnant kidney pathology after five-sixth nephrectomy in rat. I. A biochemical and morphological study. APMIS 1992;100:1097-1105.
8. Faraj AH, Morley AR. Remnant kidney pathology after five-sixth nephrectomy in rat. II. Electron microscopy study. APMIS. 1993;101:83-90.
9. Kleinknecht C, Laouari D, Burtin M. Uremic rat model: experience with young rats. Contrib Nephrol. 1988;60:27-38.
10. Sterner G, Wennberg A. Partial nephrectomy and chronic renal failure: the 'adult' rat model. Contrib Nephrol. 1988;60:39-45.
11. Ormrod D, Miller T. Experimental uremia. Description of a model producing varying degrees of stable uremia. Nephron. 1980;26:249-254.
12. Sancho JJ, Duh QY, Oms L, Sitges-Serra A, Hammond ME, Arnaud CD, Clark OH. A new experimental model for secondary hyperparathyroidism. Surgery. 1989;106:1002-1008.
13. Kimmel D, Ritz E, Krempien B, Mehls O. Bone cell kinetics and function during experimental uremia. Metab Bone Dis Relat Res. 1981;3:191-198.
14. Mehls O, Ritz E, Gilli G, Wingen AM. Osteodystrophy in experimental uremia. Contrib Nephrol. 1988;60:207-213.
15. Kraft K, Barsotti G, Giovannetti S, Wetzel E, Gretz N, Strauch M. Renal bone disease in chronic uremic rats. Contrib Nephrol. 1988;60:214-219.
16. Jablonski G, Klem KH, Attramadal A, Dahl E, Ronningen H, Gautvik KM, Haug E, Gordeladze JO. Surgically induced uremia in rats. I: Effect on bone strength and metabolism. Biosci Rep. 1993;13:275-287.
17. Jablonski G, Danielsen CC, Mosekilde L, Gordeladze JO. Surgically induced uremia in rats. II: Osseous PTH-susceptible signaling systems as predictors of bone resorption. Calcif Tissue Int. 1994;55:281-287.
18. Jablonski G, Mortensen BM, Klem KH, Mosekilde L, Danielsen CC, Gordeladze JO. Vitamin D3 analogs and salmon calcitonin partially reverse the development of renal osteodystrophy in rats. Calcif Tissue Int. 1995;57:385-391.
19. Moscovici A, Bernheim J, Popovtzer MM, Rubinger D. Renal osteodystrophy in rats with reduced renal mass. Nephrol Dial Transplant 1996;11 Suppl. 3:146-152.
20. Lopez HW, Leenhardt F, Coudray C, Remesy C. Minerals and phytic acid interactions: is it a real problem for human nutrition? International Journal for Food Science and Technology 2002;37:727-739.
21. Rimbach G, Pallauf J, Brandt K, Most E. Effect of phytic acid and microbial phytase on Cd accumulation, Zn status, and apparent absorption of Ca, P, Mg, Fe, Zn, Cu, and Mn in growing rats. Ann Nutr Metab. 1995;39:361-370.
22. Pallauf J, Rimbach G. Nutritional significance of phytic acid and phytase. Arch Tierernahr. 1997;50:301-319.
23. Schrooten I, Cabrera W, Goodman WG, Dauwe S, Lamberts LV, Marynissen R, Dorrine W, De Broe ME, D'Haese PC. Strontium causes osteomalacia in chronic renal failure rats. Kidney Int. 1998;54:448-456.
24. Tietz NW, Rinker AD, Shaw LM. IFCC methods for the measurement of catalytic concentration of enzymes Part 5. IFCC method for alkaline phosphatase (orthophosphoric-monoester phosphohydrolase, alkaline optimum, EC 3.1.3.1). J Clin Chem Clin Biochem. 1983;21:731-748.
25. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987;2:595-610.
26. Bover J, Rodriguez M, Trinidad P, Jara A, Martinez ME, Machado L, Llach F, Felsenfeld AJ. Factors in the development of secondary hyperparathyroidism during graded renal failure in the rat. Kidney Int. 1994;45:953-961.
27. Hernandez A, Concepcion MT, Rodriguez M, Salido E, Torres A. High phosphorus diet increases preproPTH mRNA independent of calcium and calcitriol in normal rats. Kidney Int. 1996;50:1872-1878.
28. Slatopolsky E, Brown A, Dusso A. Role of phosphorus in the pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis. 2001;37:S54-S57.
29. Moallem E, Kilav R, Silver J, Naveh-Many T. RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate. J Biol Chem. 1998;273:5253-5259.
30. Slatopolsky E, Caglar S, Pennell JP, Taggart DD, Canterbury JM, Reiss E, Bricker NS. On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest. 1971;50:492-499.
31. Somerville PJ, Kaye M. Evidence that resistance to the calcemic action of parathyroid hormone in rats with acute uremia is caused by phosphate retention. Kidney Int. 1979;16:552-560.
32. Naveh-Many T, Silver J. Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. J Clin Invest. 1990;86:1313-1319.
33. Portale AA, Booth BE, Halloran BP, Morris RC Jr. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest. 1984;73:1580-1589.
34. Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest. 1986;78:1296-1301.
35. Bover J, Jara A, Trinidad P, Rodriguez M, Felsenfeld AJ. Dynamics of skeletal resistance to parathyroid hormone in the rat: effect of renal failure and dietary phosphorus. Bone. 1999;25:279-285.
36. Brown AJ, Ritter CS, Finch JL, Slatopolsky EA. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate. Kidney Int. 1999;55:1284-1292.
37. Lopez-Hilker S, Dusso AS, Rapp NS, Martin KJ, Slatopolsky E. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J Physiol. 1990;259:F432-F437.
38. Naveh-Many T, Rahamimov R, Livni N, Silver J. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest. 1995;96:1786-1793.
39. Mehls O, Ritz E, Gilli G, Schmidt-Gayk H, Krempien B, Kourist B, Wesch H, Prager P. Skeletal changes and growth in experimental uremia. Nephron. 1977;18:288-300.
40. Couttenye MM, D'Haese PC, Van Hoof VO, Lemoniatou E, Goodman W, Verpooten GA, De Broe ME. Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients. Nephrol Dial Transplant. 1996;11:1065-1072.
41. Bervoets AR, Spasovski GB, Behets GJ, Dams G, Polenakovic MH, Zafirovska K, Van Hoof VO, De Broe ME, D'Haese PC. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients. Am J Kidney Dis. 2003;41:997-1007.
42. Loeb WF, Carakostas MC. Changes in serum biochemistry. In: Mohr U, Dungworth DL, Capen CC, eds. Pathobiology of the Aging Rat. Washington DC: ILSI Press; 1992:7-13.
43. Neves KR, Graciolli FG, dos Reis LM, Pasqualucci CA, Moyses RM, Jorgetti V. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. Kidney Int. 2004;66:2237-2244.